Total
0
Shares
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Reliq Health (RHT) has announced it has signed contracts with two U.S. nephrology practices
  • The two clinics will use Reliq’s proprietary iUGO Care platform to monitor patients with chronic kidney disease
  • The company will receive an average of US$65 per month for each patient under the terms of the new contracts
  • Using the iUGO Care platform, nephrologists will be able to monitor chronic kidney disease patients at home in order to help prevent disease progression
  • Shares of Reliq Health were up 3.85 per cent to C$0.54 as of 3:59 p.m. EDT

Reliq Health (RHT) has announced it has signed contracts with two U.S. nephrology practices.

The two clinics will use Reliq’s proprietary iUGO Care platform to monitor patients with chronic kidney disease (CKD). By using the platform, nephrologists will be able to monitor patients at home in order to help prevent disease progression.

Under the terms of the contracts, Reliq will receive an average of US$65 per month for each patient treated.

“It is exciting to see the rapidly increasing demand for Reliq’s iUGO Care platform with specialists in the US,” Dr. Lisa Crossley, CEO of Reliq Health Technologies, said in a statement.

She continued, “Chronic Kidney Disease typically develops as a result of uncontrolled high blood pressure and/or diabetes. Ensuring medication compliance and managing blood pressure and blood sugar in CKD patients is critical to limiting further damage to the kidneys that could lead to End Stage Renal Disease (ESRD), dependence on dialysis, the need for a kidney transplant and ultimately death.”

Based out of Hamilton, Ontario, Reliq Health Technologies is focused on developing virtual care solutions, including ones like its iUGO platform.

The iUGO platform is geared towards community-based virtual healthcare and care coordination. It is capable of treating patients who have complex conditions with high quality care at home, including improving overall health outcomes, enhancing quality of life and reducing the cost of care delivery.

Shares of Reliq Health were up 3.85 per cent to C$0.54 as of 3:59 p.m. EDT.

More From The Market Herald
Field Trip Health - President, Hannan Fleiman.

" Field Trip Health (TSX:FTRP) announces three new therapy centers

Field Trip Health (FTRP) is announcing new psychedelic-assisted therapy centers in Seattle, Vancouver and Fredericton.
Levitee Labs - CEO, Pouya Farmand.

" Levitee Labs (CSE:LVT) partners with Adracare for addiction and mental health support

Levitee Labs (LVT) has signed an agreement with Adracare to develop a platform for mental health services.

" Cardiol Therapeutics (TSX:CRDL) expands phase II/III trial of CardiolRx

Cardiol Therapeutics (CRDL) is expanding its LANCER trial to include several hospital centers in Brazil, Mexico, and Canada.

" XORTX Therapeutics (CSE:XRX) closes public offering

XORTX Therapeutics (XRX) announced the closing of a US$12M public offering.